Twist Bioscience CorporationTWSTNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank56
5Y CAGR+9.7%
Year-over-Year Change
Year-over-year SG&A expense growth
5Y CAGR
+9.7%/yr
Long-term compound
Percentile
P56
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 9.39% |
| Q3 2025 | 0.61% |
| Q2 2025 | -0.47% |
| Q1 2025 | 13.34% |
| Q4 2024 | 5.71% |
| Q3 2024 | -6.43% |
| Q2 2024 | 2.11% |
| Q1 2024 | 5.26% |
| Q4 2023 | 11.50% |
| Q3 2023 | 2.90% |
| Q2 2023 | -14.65% |
| Q1 2023 | 27.50% |
| Q4 2022 | -21.85% |
| Q3 2022 | 0.87% |
| Q2 2022 | -0.56% |
| Q1 2022 | 5.68% |
| Q4 2021 | 33.61% |
| Q3 2021 | 10.92% |
| Q2 2021 | 0.26% |
| Q1 2021 | 19.44% |
| Q4 2020 | 5.91% |
| Q3 2020 | 20.89% |
| Q2 2020 | -17.30% |
| Q1 2020 | 2.97% |
| Q4 2019 | 8.12% |
| Q3 2019 | 14.55% |
| Q2 2019 | 11.48% |
| Q1 2019 | 25.33% |
| Q4 2018 | 17.80% |
| Q3 2018 | 15.08% |
| Q2 2018 | 12.81% |
| Q1 2018 | 7.72% |
| Q4 2017 | 10.16% |
| Q3 2017 | 42.07% |
| Q2 2017 | 0.00% |